知镜 Cognispect · 医学文献与研究工作台

Use of a novel low-fat hydrolyzed diet in the management of dogs with chronic enteropathy.

Hernández-Anllo C, Feo L, Hervera M, Puig J.
Journal of veterinary internal medicine · 2026-11-01 · PMID 43008073

文献摘要

Background Dietary management plays a central role in the diagnosis and treatment of chronic enteropathy (CE) in dogs. Although hydrolyzed-protein diets are commonly used in patients with CE, and dietary fat restriction is recommended in selected gastrointestinal disorders, the combined effect of low fat and hydrolyzed protein has not been specifically evaluated. Hypothesis/objectives Assess clinical response and acceptability of a low-fat, hydrolyzed diet in dogs with CE. Animals Thirty-one client-owned dogs. Methods Prospective clinical study. Dogs were fed a commercial low-fat (2.01 g/100 kcal metabolizable energy) hydrolyzed salmon protein diet and stratified according to previous dietary history. Dogs were evaluated at baseline, 1 month, and 3 months. The primary outcome was clinical response, classified as complete response (CR), partial response (PR), or non-response (NR) based on gastrointestinal signs and the Canine Inflammatory Bowel Disease Activity Index (CIBDAI) score. Dogs with CR or PR were considered responders. Diet acceptability was assessed. Results At T1, 20 of 31 (64.5%) dogs were categorized as CR, 3 of 31 (9.7%) as PR, and 8 of 31 (25.8%) as NR. Twenty-three of 31 (74.2%) dogs had a positive clinical response. The CIBDAI scores decreased significantly from T0 to T1 (P Conclusions and clinical importance This low-fat, hydrolyzed diet had significant short- and mid-term effectiveness and was well tolerated in dogs with CE, reinforcing its potential as a treatment for food-responsive enteropathy.

在知镜精读原文来源DOI 原文

知镜提供医学文献检索、阅读笔记、人体图谱、统计绘图与研究复现工具。